-+ 0.00%
-+ 0.00%
-+ 0.00%

Dexco Q3 2026 adjusted recurring pro forma EBITDA rises 38% year over year to R$ 783.63 million

PUBT·11/04/2026 22:35:58
Listen to the news
Dexco Q3 2026 adjusted recurring pro forma EBITDA rises 38% year over year to R$ 783.63 million
  • Dexco’s third-quarter 2026 adjusted recurring pro forma EBITDA rose 38% year over year to BRL 783.63 million, including its LD Celulose share.
  • The recurring net loss narrowed 87% year over year to BRL 5.5 million.
  • Pro forma net revenue climbed 10% year over year to BRL 2.34 billion, primarily supported by the wood division.
  • Industrial restructuring includes closing the Recife sanitaryware plant and concentrating production in Jundiaí, supplemented by outsourced manufacturing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dexco SA published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.